Mometason Glenmark (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometason Glenmark, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various dermatologic conditions such as psoriasis, eczema, atopic dermatitis and contact dermatitis, primarily in adult and pediatric patients under medical supervision.

GNH USA supplies Mometason Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Mometasone furoate is a topical corticosteroid that modulates inflammatory pathways in skin disorders. - Psoriasis: reduces plaque thickness, scaling and erythema. - Eczema: alleviates itching and inflammation. - Atopic dermatitis: improves skin barrier function and decreases flare severity. - Contact dermatitis: diminishes allergic skin reactions and redness.

Topical application of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Burning or stinging at the application site. - Dryness or peeling of the skin. - Mild itching or erythema.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels). - Secondary bacterial, fungal or viral skin infections.

When using Mometason Glenmark, several precautions should be observed to minimize risks and ensure optimal therapeutic outcomes. - Application area: limit to affected skin and avoid large surface areas. - Duration of therapy: use for the shortest effective period, typically not exceeding two weeks without medical review. - Occlusion: avoid covering treated skin with dressings unless directed by a clinician. - Pediatric use: exercise caution in children; monitor for signs of systemic absorption. - Contraindications: do not use on infected, ulcerated or compromised skin without physician guidance. - Store at room temperature: keep below 25 °C in the original container, protected from moisture and direct sunlight.

Mometasone furoate can interact with other medications, affecting its safety or efficacy.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug levels, enhancing adverse skin reactions. - Antiviral agents for herpes simplex: may reduce antiviral efficacy if skin barrier is compromised.

Moderate Interactions (Monitor Closely): - Immunosuppressants (e.g., cyclosporine): may increase susceptibility to skin infections. - Antifungal topicals: combined use may alter absorption, requiring monitoring. - Phototherapy: concurrent use may heighten skin irritation.